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Abstract 
 
Alzheimer’s disease is a progressive, neurodegenerative disorder characterized by the 
accumulation of amyloid β (Aβ) plaques in affected brain regions.  Strong evidence 
indicates that Aβ exerts neurotoxic effects by promoting mitochondrial dysfunction and 
ROS production, leading to widespread oxidative damage and activation of pro-apoptotic 
mechanisms.  Past investigations suggest that neuronal resistance to Aβ toxicity is partly 
mediated by a Warburg Effect-like metabolism, in which cells exhibit elevated glycolytic 
activity and lactate production, while limiting mitochondrial respiration.  Elevated lactate 
dehydrogenase A (LDHA) activity, which catalyzes lactate production from pyruvate, has 
been demonstrated to counter Aβ-induced oxidative stress and neurotoxicity, however the 
role of LDHB, which catalyzes the reverse reaction, has not been determined in this 
regard.  This study utilized Aβ-sensitive and resistant PC12 cell lines, derived from a 
tumour of the rat adrenal medulla, and sought to determine the effect of altered LDHB 
protein levels on mitochondrial membrane potential, mitochondrial ROS levels, and cell 
viability following treatment with Aβ.  Elevated levels of LDHB were detected in Aβ-
resistant PC12 cells, compared to sensitive cells.  Attenuation of LDHB expression using 
shRNA-mediated silencing resulted in increased mitochondrial membrane potential, ROS 
levels, and neurotoxicity in Aβ-resistant PC12 cells.   Additionally, the effect of 
monocarboxylate (pyruvate and lactate) transport inhibition on PC12 cell viability, was 
investigated.  In contrast to Aβ-sensitive PC12 cells, resistant cells were tolerant of 
monocarboxylate transporter inhibition while all cell lines were intolerant of 
mitochondrial pyruvate transporter inhibition.  These findings indicate that LDHB may 
regulate mitochondrial respiration and sensitivity to Aβ in PC12 cells. 
Key words: Lactate dehydrogenase isoform B, Reactive oxygen species, 
mitochondrial membrane potential, amyloid beta, hydrogen peroxide, 
monocarboxylate transport  
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Chapter 1: Introduction 
 
1.1 – Alzheimer’s disease Overview 
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative disorders 
impacting the aging population and is characterized by progressive memory loss, 
cognitive decline and, eventually death.  Initially described by Alois Alzheimer in 1906, 
AD accounts for up to 80% of all cases of dementia and has a tremendous financial 
impact on society (Alzheimer’s Association 2014).  In 2010, over 36 million individuals 
were estimated to be suffering from dementia worldwide, with treatment costs of patients 
suffering from AD and related dementias estimated at $604 billion (Alzheimer’s Disease 
International 2012).  By 2050, it is estimated that 115 million individuals will suffer from 
AD, and associated healthcare costs are expected to increase dramatically as a result 
(Alzheimer’s Disease International 2012).   
 
Currently, there is no cure for AD and treatment options remain limited, necessitating 
further research into causes and potential new therapies for the disease.  Increasing age 
remains the greatest risk factor for developing AD, with the majority of affected 
individuals developing the disease sporadically after 65 years of age (late onset AD).  
However, mutations in amyloid precursor protein (APP), Presenilin 1 (PSEN1) or 
Presenilin 2 (PSEN2) lead to an early onset familial form of AD (Chartier-Harlin et al. 
1991; Levy-Lahad et al. 1995).  AD pathology is characterized by the accumulation of 
extracellular amyloid beta (Aβ) plaques and intraneuronal neurofibrillary tangles (NFTs) 
in the brain; two events associated with neuronal cell death.   
 
The cortex and hippocampus, which govern higher cognitive functions and memory, 
respectively, are brain regions that degenerate during AD progression and exhibit 
significant plaque and tangle accumulation (Schmechel et al. 1993; West et al. 1994).  
The extracellular plaques are formed by the aggregation of Aβ peptides, a 40-42 amino 
acid peptide produced from the proteolytic cleavage of amyloid precursor protein (APP) 
by beta-secretase and the gamma-secretase intramembrane protease complex.  NFTs are 
formed following hyperphosphorylation of the microtubule-associated protein tau, 
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causing it to self-aggregate (Bancher et al. 1989).  As a result, neuronal microtubule 
organization becomes compromised due to the inability of tau to bind and stabilize them.   
 
1.2 – Causes of Alzheimer’s disease 
Although the exact mechanism driving AD progression is currently unknown, the 
production and accumulation of Aβ peptides and plaques within the brain are strongly 
suggested to be the primary causative factor in AD pathogenesis and development.  This 
view, known as the amyloid hypothesis, has garnered much support within the scientific 
community.  First, individuals possessing mutations in APP, PSEN1, or PSEN2 develop 
early-onset familial AD (Chartier-Harlin et al. 1991; Levy-Lahad et al. 1995).  Mutations 
in APP favour proteolytic processing of APP by beta and gamma secretases, and have 
been demonstrated to promote Aβ peptide formation and accumulation in vivo (Scheuner 
et al. 1996).  Mutations in PSEN1 and PSEN2 also result in increased Aβ peptide 
production in vivo (Scheuner et al. 1996).  In addition, inheritance of the apolipoprotein E 
(APOE) ε4 allele has been identified as a major risk factor for the development of late-
onset AD, where up to 80% of individuals suffering from the disease possess at least one 
copy of APOEε4 (Mahley et al. 2006).  The APOE family is a class of apolipoproteins 
that promote the proteolytic degradation or clearance of Aβ peptide, however, the 
APOEε4 isoform is not nearly as effective at accomplishing this task (Jiang et al. 2008).  
Therefore, individuals possessing one or more copies of the APOEε4 allele exhibit 
increased risk of Aβ plaque accumulation in the brain compared to those who have not 
inherited it (Jiang et al. 2008).  Furthermore, mutations in Triggering receptor expressed 
on myeloid cells 2 (TREM2), a gene encoding Ig superfamily receptors involved in 
inflammatory responses, have been associated with compromised microglia-mediated 
clearance of Aβ plaques from the human brain, increasing the likelihood of developing 
late onset AD (Guerreiro et al. 2013; Jonsson, et al. 2013).  
 
Investigations by De Felice et al. (2007) have shown that, in rat hippocampal neurons and 
neuroblastoma cells, soluble Aβ oligomers promote tau phosphorylation at specific 
epitopes demonstrated to be hyperphosphorylated in AD.  Additionally, studies in which 
mice overexpress mutant APP (mAPP) and tau exhibit NFT accumulation in the cortex 
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and hippocampus, whereas mice overexpressing mutant tau alone do not (Lewis et al. 
2001).  Therefore, these studies suggest that Aβ promotes the formation and deposition of 
NFTs in brain regions affected by AD. Taken together, these findings provide compelling 
evidence supporting Aβ production and accumulation as the primary driving force for AD 
pathogenesis and progression. 
 
1.3 – APP Processing and Aβ Peptide Formation 
APP is a highly conserved, widely expressed transmembrane protein present in both 
vertebrate and invertebrate species.  APP is highly localized to neuronal membranes, 
including the endoplasmic reticulum (ER) and Golgi complex, the plasma membrane, as 
well as mitochondrial membranes (Hartmann et al. 1997).  Although the physiological 
role of APP is not well characterized, recent studies suggest that it may regulate synapse 
formation and function, neuroplasticity, and hormonal regulation (Priller et al. 2006).  
Interestingly, only the vertebrate form of the APP protein contains the pathological 40 – 
42 peptide fragment sequence associated with AD (Tharp and Sarkar 2013).  Like many 
other proteins, APP is subject to a host of post-translational modifications, including 
phosphorylation, glycosylation, but also proteolytic cleavage, which can result in the 
generation of Aβ peptides.  Proteolytic processing of APP is accomplished by secretases, 
and the resulting peptides can be classified as either amyloidogenic, which results in the 
formation of the neurotoxic Aβ peptide, or non-amyloidogenic.  In non-amyloidogenic 
processing, alpha secretases prevent pathological Aβ production by cleaving within the 
APP fragment that normally gives rise to Aβ peptide (De Strooper and Annaert 2000; 
Selkoe et al. 1998).  This yields a non-pathological, soluble p3 peptide that can be readily 
cleared by the brain (Selkoe et al. 1998).  However, in amyloidogenic processing, APP is 
sequentially cleaved by beta and gamma secretases, the latter of which forms a complex 
with PSEN1 and PSEN2 to fulfill its function.  Cleavage of the extracellular APP domain 
by beta secretases yields a membrane-bound amyloidogenic C-terminal fragment (C99), 
which is subsequently processed by the gamma secretase protease complex, releasing the 
pathogenic Aβ peptide (Selkoe et al. 1998).  The Aβ peptide formed is typically 36 – 43 
amino acids in length, with the Aβ40 and Aβ42 isoforms being the most prevalent 
(Hartmann et al. 1997).  Aβ peptides, in particular the Aβ42 isoform, readily self-
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aggregate, forming soluble oligomers and insoluble fibrils and plaques, all of which are 
neurotoxic and promote progression of AD pathology. 
 
1.4  – Oxidative Stress in the AD Brain 
In addition to the Aβ plaque and NFT accumulation typical of AD pathology, many 
studies have also observed that the AD brain displays markers of increased oxidative 
stress and damage (Zhao and Zhao 2013; Butterfield et al. 2001; Markesbery 1997).  
Numerous studies have suggested that Aβ accumulation in the AD brain promotes an 
imbalance between the production and clearance of reactive oxygen species (ROS) by 
antioxidant defense mechanisms (Butterfield et al. 2001; Markesbery 1997).  ROS are an 
oxygen-containing class of chemically reactive molecules typically formed as byproducts 
of normal cellular metabolism.  Common forms of ROS found in cells include superoxide 
radicals (O2) and hydroxyl radicals (OH), the latter of which is derived from hydrogen 
peroxide (H2O2).  Despite having beneficial physiological roles, including maintaining 
cellular homeostasis and acting as second messengers in cell signaling, ROS, at high 
concentrations, can cause extensive damage to cellular structures and molecules, 
including lipids, nucleic acids, and proteins, thereby impairing function and promoting 
disease states (Devasagayam et al. 2004; Markesbery 1997; Halliwell 1987; Halliwell 
and Cross 1994).  Lipids, principle components of cellular membranes, readily undergo 
ROS-induced peroxidation that can compromise membrane integrity and function 
(Butterfield et al. 2001; Markesbery 1997).  Oxidative damage to nucleic acids can 
promote mutagenesis and carcinogenesis, while protein oxidation can negatively impact 
enzyme structure, and therefore function (Butterfield et al. 2001; Markesbery 1997).  
Antioxidant defense systems protect against oxidative damage by neutralizing potentially 
harmful ROS.  These systems include manganese superoxide dismutase (Mn-SOD), 
catalases, peroxiredoxins, and glutathione peroxidases.   
 
The human brain possesses several characteristics that make it extremely susceptible to 
oxidative damage, which is readily apparent in AD. First, the brain derives approximately 
95% of its energy, in the form of ATP, from the oxygen-dependent metabolism of 
glucose in mitochondria (Chandrasekaran et al. 1994).  This process, also known as 
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oxidative phosphorylation (OXPHOS), depends upon the transfer of electrons between 
protein complexes embedded in the inner mitochondrial membrane (IMM), to generate a 
proton (H+) gradient across the IMM, which is used to drive ATP production.  In 
addition, OXPHOS is also a major potential source of intracellular ROS production.  In 
the AD brain, mitochondrial electron transfer is impaired due to decreased ETC protein 
complex activity, resulting in the accumulation of H+ in the mitochondrial intermembrane 
space (IMS), and thus, an increased mitochondrial membrane potential (Δψm) across the 
IMM (Parker et al. 1994; Lin and Beal 2006; Chandrasekaran et al. 1994; Manczak et al. 
2006).  These conditions increase the likelihood of electron off-loading from the ETC to 
react with available oxygen, forming ROS and promoting widespread oxidative damage 
in the brain (Lin and Beal 2006; Manczak et al. 2006). Oxidative damage observed in the 
AD brain includes significantly increased nuclear and mitochondrial DNA oxidation, 
lipid peroxidation, as well as protein oxidation (Markesbery 1997; Butterfield et al. 
2001).  Second, studies demonstrate that the brain has significantly reduced levels of 
antioxidant defenses, such as SOD and catalase activity, compared to other tissues 
(Lovell et al. 1998; Behl 1997; Marcus et al. 1998).  In AD, this inability to effectively 
detoxify ROS may result in increased oxidative damage and eventual neuronal cell death 
in the brain (Behl 1997; Marcus et al. 1998).  Third, the brain has a naturally high lipid 
content, specifically polyunsaturated fats (PUFAs), which are readily oxidizable by ROS 
(Butterfield et al. 2001; Markesbery 1997).  In AD, elevated concentrations of ROS in 
the brain induce the peroxidation of PUFAs and subsequent formation of 4-
hydroxynonenal (4-HNE), a highly reactive byproduct that promotes oxidative damage 
and neurotoxicity (Butterfield et al. 2001; Markesbery and Lovell 1998).  4-HNE has 
been shown to inhibit glycolysis, as well as nucleic acid and protein synthesis.  4-HNE is 
also involved in protein oxidation.   For example, treatment of rat hippocampal neurons 
with Aβ has proven to significantly increase levels of 4-HNE, which directly impairs 
Na+/K+ ATPase activity and increases intracellular levels of calcium.  This disruption of 
calcium homeostasis promoted further ROS production and cytotoxicity, resulting in 
neuronal cell death (Mark et al. 1997).  Furthermore, the activity of glutathione S-
transferase, an antioxidant enzyme that mediates detoxification of 4-HNE, is significantly 
decreased in all brain regions of AD patients compared to controls (Lovell et al. 1998).  
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Thus, the brain has a large capacity for the production of ROS, and is also highly 
susceptible to ROS-induced damage due to its physiology and metabolism.  Together, 
these observations provide support for the Oxidative Stress Hypothesis of AD, which 
suggests that the accumulation of oxidative damage in the brain over time contributes to 
the progressive neurodegeneration characteristic of the disease.  Interestingly, mounting 
evidence suggests that the observed increase in oxidative damage in the AD brain may be 
directly attributable to Aβ accumulation and mitochondrial dysfunction. 
 
1.5 – Aβ Accumulation in the Brain is Associated with Increased Oxidative Stress 
For the past two decades, studies have presented growing evidence that Aβ may exert its 
toxic effect, in part, by elevating oxidative stress in the brain.  Investigations by Behl et 
al. (1994) demonstrate that treatment of primary and clonal cell lines, derived from the 
mammalian central nervous system (CNS), with exogenous Aβ is neurotoxic and induces 
significant intracellular accumulation of H2O2 in a concentration and time-dependent 
manner.  Treatment of these cell lines with Aβ in the presence of various enzymatic and 
non-enzymatic antioxidants rescues cell viability and reduces intracellular levels of H2O2, 
while treatment with increasing concentrations of H2O2 alone mimics the detrimental 
effect of Aβ on cell survival (Behl et al. 1992; Behl et al. 1994).  Interestingly, clonal cell 
lines that were continually selected for resistance to Aβ, are also resistant to H2O2 
toxicity (Behl et al. 1994).  Later in vivo studies corroborated these findings by 
demonstrating that the production of H2O2, and other ROS, are directly correlated with 
levels of soluble Aβ peptides (Manczak et al. 2006; McLellan et al. 2003; Xie et al. 
2013).  In a similar fashion to cell culture models, Aβ-induced increases in oxidative 
stress results in neuronal degeneration of the transgenic AD mouse brain in vivo 
(Manczak et al. 2006; McLellan et al. 2003; Xie et al. 2013).  These works suggest that, 
both in vitro and in vivo, the neurotoxic effect of Aβ may be mediated by H2O2 or one of 
its derivatives.  Furthermore, other studies have shown that H2O2 may mediate its toxic 
effect via its conversion to OH.  H2O2, in the presence of iron or copper ions, readily 
oxidizes iron (II) to iron (III) with the production of OH as a byproduct, a process 
known as the Fenton reaction (Halliwell and Gutteridge 1984).  Interestingly, both 
oxidation states of iron have been shown to specifically localize with Aβ plaques and 
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NFTs in the human AD brain (Smith et al. 1997).  OH, one of the most reactive forms of 
ROS, readily promotes oxidative damage within cells, including protein and nucleic acid 
oxidation as well as lipid peroxidation (Halliwell and Cross 1994; Halliwell and 
Gutteridge 1990).  Moreover, reaction of OH with other biomolecules has the potential 
to produce additional ROS, potentiating further oxidative damage (Halliwell and 
Gutteridge 1990).  Due to its extremely short half-life (approximately 10-9 seconds) and 
high rate of reaction (rate constant ≅ 109 – 1010 M-1sec-1), OH is difficult to detoxify and 
rapidly reacts with biological molecules, making it one of the most dangerous and 
potentially devastating form of oxygen free radicals (Sies 1993; Halliwell and Cross 
1994). 
 
H2O2 accumulation in AD has been suggested to promote further Aβ production by 
potentially increasing the activity of β- and γ-secretases in vitro and in vivo.   
Investigations by Bourne et al. (2007) revealed that H2O2 activates nuclear factor-kappa-
light-chain-enhancer of activated B cells (NF-κB), a transcription factor involved in stress 
response and cell survival, in neuronal cell populations.  NF-κB is also activated in 
response to exogenous Aβ exposure (Behl et al. 1994).  The promoter of the human β-
secretase/β-site APP cleaving enzyme (BACE1) gene contains a NF-κB binding site, and 
studies in which NF-κB subunit p65 is overexpressed resulted in increased activity of β-
secretase as well as increased Aβ production in human neuroblastoma cell lines (Chen et 
al. 2012).  Alternatively, in a study by Tamagno et al. (2005), 4-HNE, the reactive 
byproduct formed from ROS-induced lipid peroxidation, increases the expression and 
activity of β-secretase as well, resulting in increased Aβ accumulation.  In addition, H2O2 
enhances γ-secretase-mediated cleavage of C99 in human neuroblastoma SH-SY5Y cells 
by promoting the phosphorylation and activation of c-Jun N-terminal kinase (JNK), a 
stress-activated enzyme that modifies the activity of other proteins via phosphorylation 
(Shen et al. 2008).  Although active JNK (p-JNK) appears to be required for H2O2-
induced increases in γ-secretase activity and C99 cleavage, the underlying molecular 
mechanism by which this occurs remains to be determined (Shen et al. 2008).  
Interestingly, p-JNK was observed to co-localize in brain regions surrounding Aβ plaques 
in the AD transgenic mouse model Tg2576 (Shen et al. 2008).  Moreover, hippocampal 
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and cortical brain tissues from AD patients express higher levels of p-JNK compared to 
controls (Shen et al. 2008).  Together, these findings suggest that Aβ-induced increases 
in H2O2 and other ROS induce the oxidative damage and neurotoxicity associated with 
AD, but may also increase the activity of β- and γ-secretases, further potentiating Aβ 
production in a positive feedback loop.  Therefore, these studies provide strong evidence 
that Aβ may mediate its neurotoxic effect through ROS.  
 
1.6 – Aβ-induced Mitochondrial Dysfunction and Oxidative Stress 
Although it only accounts for approximately 2% of total body weight, the human brain 
requires large amounts of energy to function, utilizing as much as 20 – 25% of total body 
metabolism (Mink et al. 1981).  Glucose is the primary metabolite processed by the brain 
to yield usable energy in the form of ATP, however lactate and ketone bodies can also be 
metabolized.  Specifically, glucose is converted into pyruvate in the cytosol via a series 
of enzyme-catalyzed reactions, a process known as glycolysis.  Glycolysis also yields the 
electron carrier NADH and ATP, as byproducts.  Pyruvate is then imported into the 
mitochondrial matrix and converted to acetyl coenzyme A (acetyl-CoA), via the activity 
of the pyruvate dehydrogenase (PDH) complex, with concomitant NADH production.  
Acetyl-CoA is further processed via the Krebs cycle to CO2, yielding the electron carriers 
NADH and FADH2.  The majority of glucose-derived ATP, required for proper neuronal 
function, is produced via OXPHOS.  OXPHOS is dependent upon the transfer of 
electrons, donated by NADH and FADH2, between protein complexes embedded in the 
IMM, which compose the mitochondrial ETC.  This electron transfer generates a H+ 
gradient across the IMM, increasing the Δψm as a result.  The H+ gradient is used by the 
enzyme ATP synthase to produce enough ATP to meet a neuron’s energy requirements.   
 
In addition to ATP production, mitochondria are also a major source of endogenous ROS 
in neuronal cells and are also important regulators of apoptosis.  During normal 
OXPHOS, a small percentage of electrons may leak from the ETC, univalently reducing 
oxygen and forming O2 as a byproduct.  In neuronal mitochondria, Mn-SOD neutralizes 
O2 by converting it to O2 and H2O2.  Mitochondrial dysfunction, characterized by 
decreased activity of the ETC protein complexes, results in increased electron leakage 
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and ROS production, promoting oxidation of mitochondrial proteins, DNA, and lipids 
(Butterfield et al. 2001; Markesbery 1997).  Increasing oxidative damage within the 
mitochondria eventually results in the release of cytochrome c, a component of the 
mitochondrial ETC, to the cytoplasm, where it can initiate apoptosis-mediated neuronal 
cell death by promoting capase-9 activity. 
 
Previous studies have suggested that Aβ may play a role in promoting increased 
mitochondrial dysfunction and ROS production in AD, although the exact mechanism by 
which this is accomplished has not been well characterized.  For example, in vivo studies 
of transgenic mice expressing mutant APP (tg-mAPP) demonstrate gradual accumulation 
of Aβ in the mitochondrial matrix of neurons derived from the cerebral cortex (Manczak 
et al. 2006).  Interestingly, this accumulation is closely associated with decreased activity 
of coenzyme Q-cytochrome c reductase (complex III) and cytochrome c oxidase 
(complex IV), two major protein complexes of the mitochondrial ETC (Manczak et al. 
2006).  Further investigations suggest that this mitochondrial dysfunction may be partly 
mediated by the interaction of Aβ and amyloid-beta peptide binding alcohol 
dehydrogenase (ABAD).  ABAD, primarily localized within the mitochondria of 
neurons, oxidizes a wide variety of alcohol substrates (Chen and Yan 2007).  ABAD is 
upregulated in AD-afflicted brain regions of tg-mAPP mice, including the hippocampus 
and cortex, and readily binds Aβ peptides and oligomers (Lustbader et al. 2004; Chen and 
Yan 2007; He et al. 2002; Yan et al. 1997).  Studies in cultured neurons derived from 
transgenic mice expressing mAPP and ABAD (tg-mAPP/ABAD) by Takuma et al. 
(2005) suggest that elevated levels of mitochondrial-derived ROS, specifically O2 and 
H2O2, are due to decreased enzymatic activity of ETC complex IV, and is dependent on 
the interaction between Aβ and ABAD.  In addition, these neurons also display increased 
caspase-3-like activity, suggesting that this Aβ-ABAD interaction, by promoting 
mitochondrial dysfunction, induces enough oxidative damage to produce a cytotoxic 
environment to neurons, resulting in apoptosis-mediated cell death (Takuma et al. 2005).  
Interference of Aβ-ABAD binding, however, prevents increased mitochondrial ROS 
production and related oxidative damage (Takuma et al. 2005). 
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1.7 – Resistance to Aβ Toxicity: The Warburg Effect 
Despite the abundant amount of evidence supporting a strong association between Aβ 
accumulation and ROS-mediated neuronal toxicity, it has been observed that nearly 30% 
of elderly individuals demonstrate a significant degree of Aβ plaque accumulation in 
various brain regions, yet they do not exhibit the characteristic neuronal cell death or 
cognitive impairment associated with AD (Price and Morris 1999; Bouras et al. 1994).  
Intriguingly, this suggests that the neurons of these individuals may have an innate 
resistance mechanism that protects against progressive Aβ accumulation and the 
neurotoxic environment that it creates. 
 
In order to better understand how Aβ-resistance arises, past investigations have 
continuously treated Aβ-sensitive neuronal cell lines with toxic levels of Aβ and isolated 
any emergent surviving populations as Aβ-resistant clonal cell lines.  These stable Aβ-
resistant cell lines demonstrated a characteristic increase in glucose uptake and 
metabolism, an extreme sensitivity to glucose starvation, and preferentially utilized 
glycolysis over mitochondrial respiration as a primary form of ATP production, even 
under normal oxygen conditions (Soucek et al. 2003).  This phenomenon, known as 
Aerobic Glycolysis, or the Warburg Effect, was first studied and characterized in cancer 
cell models and is partially mediated through the activity of hypoxia inducible factor-1 
(HIF-1) (Figure 1) (Soucek et al. 2003; Semenza et al. 2007).   
 
HIF-1 is a heterodimeric protein, composed of HIF-1α and HIF-1β subunits that function 
in transcriptional activation and nuclear translocation, respectively (Wang and Semenza 
1995; Jiang et al. 1996).  HIF-1α binds HIF-1β to form the fully functional HIF-1 
heterodimer under hypoxic conditions, however, at higher oxygen concentrations, HIF-1α 
is hydroxylated by prolyl hydroxylases, ubiquitinated and then degraded via the 
proteasome (Maxwell et al. 1999).  In cancer cells, HIF-1α is stabilized, allowing HIF-1 
to act as a transcription factor to induce the expression of many genes involved in cellular 
metabolism, including pyruvate dehydrogenase kinase 1 (PDK1) (Kim et al. 2006; 
Semenza et al. 2007).  PDK1 functions by phosphorylating and inhibiting PDH, the  
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Figure 1. Proposed model of Aerobic Glycolysis (The Warburg Effect).  
Increased HIF-1 activity in Aβ-resistant neuronal cells results in upregulation of 
glucose transporters and glycolytic enzymes, thereby increasing glucose conversion 
to pyruvate in the cytosol.  Furthermore, HIF-1 activity promotes the reduction of 
pyruvate to lactate by increasing the activity of lactate dehydrogenase A (LDHA).  
HIF-1 also increases activity of pyruvate dehydrogenase kinase 1 (PDK1), which 
phosphorylates and inhibits pyruvate dehydrogenase (PDH), inhibiting conversion of 
pyruvate to acetyl coenzyme A (acetyl-CoA) in the mitochondrial matrix.  Lack of 
availability of acetyl-CoA prevents the generation of reducing equivalents required 
for oxidative phosphorylation across the IMM.  Decreased activity of electron 
transport may lower the probability of reactive oxygen species (ROS) generation in 
the mitochondria, thereby conferring resistance to Aβ-mediated toxicity.  Dashed 
lines represent HIF-1-mediated upregulation of enzymatic activity. Reproduced from 
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mitochondrial matrix-localized enzyme complex that catalyzes the decarboxylation of 
pyruvate to acetyl-CoA.  Inhibition of PDH reduces the availability of acetyl-CoA, the 
substrate utilized by the Krebs cycle, to generate the electron carriers NADH and 
FADH2, which are ultimately used to drive ATP production via OXPHOS in the 
mitochondria.  Interestingly, HIF-1 also increases expression of many glucose 
transporters and glycolytic enzymes, including glucose transporter-1 (Glut1), aldolase A, 
and enolase 1 (Semenza et al. 1996).  In addition, HIF-1 promotes the expression of 
lactate dehydrogenase isoform A (LDHA), an enzyme that catalyzes the conversion of 
pyruvate to lactate, with the concomitant oxidation of NADH to NAD+ (Semenza et al. 
1996).  LDHA, together with the lactate dehydrogenase isoform B (LDHB) enzyme, form 
the tetrameric holoenzyme lactate dehydrogenase (LDH).  It is currently unknown 
whether or not HIF-1 regulates LDHB expression, although future studies could be 
conducted to determine if HIF-1 binds the LDHB promoter.  In contrast to LDHA, LDHB 
catalyzes the conversion of lactate to pyruvate coupled with the reduction of NAD+ to 
NADH.  Both LDHA and LDHB are nuclear-encoded and located on chromosome 11 and 
12, respectively.  The relative number of LDHA or LDHB enzymatic subunits composing 
LDH determines the overall activity of the holoenzyme.  For instance, there	   are	   5	  distinct	   LDH	   holoenzymes	   determined	   by	   the	   LDHB	   to	   LDHA	   ratio:	   LDH1	   (4:0),	  LDH2	  (3:1),	  LDH3	  (2:2),	  LDH4	  (1:3),	  and	  LDH5	  (0:4).	  	  Therefore, through the activity 
of HIF-1, lactate production is increased and mitochondrial respiration is decreased in 
cancer cells, suggesting this cell type is highly dependent on glycolysis to produce ATP, 
in order to maintain normal energy requirements. 
 
Previous investigations revealed that Aβ-resistant neuronal cell populations may adopt a 
Warburg Effect-like metabolism, demonstrating increased HIF-1, PDK1, and LDHA 
activity in comparison to Aβ-sensitive controls (Soucek et al. 2003; Newington et al. 
2011).  While knockdown of PDK1 or LDHA in Aβ-resistant PC12 cells induces re-
sensitization to Aβ toxicity (Newington et al. 2011), overexpression of PDK1 or LDHA 
in Aβ-sensitive neuronal cells has been shown to confer resistance to toxic levels of 
exogenous Aβ and H2O2, both of which induce apoptosis-mediated cell death (Newington 
et al. 2012).  Furthermore, PDK1 or LDHA overexpressing cells display decreased 
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oxygen consumption and Δψm, but maintain ATP levels comparable to cells expressing 
low levels of PDK1 or LDHA (Newington et al. 2012).  In addition, Aβ-sensitive cells 
overexpressing PDK1 or LDHA exhibit significantly decreased mitochondrial ROS 
levels following treatment with exogenous Aβ, compared to controls (Newington et al. 
2012).  Taken together, these data suggest that PDK1 or LDHA overexpression may 
confer Aβ resistance in mammalian neuronal cell populations by inhibiting mitochondrial 
respiration and ROS production, while maintaining normal ATP levels through the 
glycolytic pathway.  Thus aerobic glycolysis may provide a general resistance 
mechanism to Aβ and other toxins in neurons. 
 
1.8 – Lactate Metabolism and The Intracellular Lactate Shuttle Hypothesis 
Although increased LDHA activity appears to be important for imparting resistance to Aβ 
toxicity in neuronal cells, the role of lactate and its metabolism have not been 
investigated in this regard.  Typically, lactate has been considered a metabolic waste 
product that becomes cytotoxic at high concentrations and is removed from neuronal cells 
via monocarboxylate transporters (MCT) 1, 2, and 4.  However, lactate may play a vital 
role for proper neuronal function, as a number of studies have found that lactate is 
preferred over glucose as an energy substrate in neurons (Bouzier-Sore et al. 2003; Wyss 
et al. 2011).  Metabolism of lactate is achieved primarily through the activity of LDH.  
 
Brain metabolism of lactate has been previously examined from the perspective of the 
Intracellular Lactate Shuttle (ILS) Hypothesis, which suggests that LDHA and LDHB 
may be localized in different subcellular compartments (Santos de Oliveira Cruz et al. 
2012; Brooks et al. 1999) (Figure 2).  Specifically, the ILS Hypothesis posits that, in the 
cytosol, LDHA catalyzes the reduction of pyruvate to lactate.  Lactate is then transported 
across the outer mitochondrial membrane (OMM), and is oxidized back to pyruvate, via 
the catalytic activity of LDHB, in the IMS.  Pyruvate can then be co-transported with H+ 
from the IMS to the mitochondrial matrix via monocarboxylate transporters (MCTs) or 
the mitochondrial pyruvate carrier (MPC) embedded in the IMM.  Alternatively, lactate 
may be co-transported with H+ directly to the mitochondrial matrix by MCTs, where it is  
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Figure 2. Schematic of the Intracellular Lactate Shuttle Hypothesis.  Lactate is a 
monocarboxylate transported into the mitochondrial intermembrane space. Cytosol-
localized pyruvate is reduced to lactate, which is imported into the mitochondrial matrix 
via MCT transporters.  Matrix-localized LDHB promotes the oxidation of lactate to 
pyruvate, which then enters the TCA cycle to yield reducing equivalents for OXPHOS.  
Lactate may also be converted to pyruvate in the intermembrane space.  The effect of 
altered NADH/NAD+ ratios on OXPHOS following increased LDHB activity is currently 
unknown.  Solid lines represent a proposed pathway by which lactate or pyruvate may be 
imported into the mitochondria, while dashed lines represent an alternate pathway.  
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then oxidized to pyruvate by LDHB within the mitochondrial matrix.  PDH then 
catalyzes the conversion of pyruvate to acetyl-CoA, which is then processed by the TCA 
cycle and OXPHOS to generate ATP.  Interestingly, this co-transport of H+ with either 
pyruvate or lactate may help protect against oxidative stress by partly dissipating the Δψm 
and reducing the likelihood of mitochondrial ROS production.  Recent investigations by 
Hashimoto et al. (2008) support the notion of mitochondrial-localized oxidation of lactate 
via a mitochondrial lactate oxidation complex (mLOC), composed of cytochrome 
oxidase, MCT1/2, and LDHB, in the IMM of rat neuronal cells.  This mLOC readily 
mediates the conversion of lactate to pyruvate in the IMS (Hashimoto et al. 2008).  
Although this suggests that neurons may possess intracellular machinery allowing them 
to metabolize lactate, the impact of mitochondrial-localized LDHB on mitochondrial 
activity is not well characterized.  It should be noted, however, that the intracellular 
localization of LDHA and LDHB, in either the cytosol or mitochondria, remains 
controversial.  Furthermore, despite evidence suggesting that lactate metabolism plays a 
vital role in neuronal function, the mechanism by which it may mediate Aβ-resistance 
remains to be determined. 
 
1.9 – Rationale, Hypothesis, and Research Outline 
Resistance to Aβ toxicity is observed in neuronal cell populations that adopt a Warburg 
Effect-like metabolism, where glucose uptake and glycolysis are upregulated but 
mitochondrial respiration is diminished (Newington et al. 2011; Newington et al. 2012).  
As a result, neuronal cells are able to maintain normal levels of ATP, while mitochondrial 
ROS production and oxidative stress are limited (Newington et al. 2011; Newington et al. 
2012).  In addition, LDHA is another important enzyme that helps mediate this 
resistance, as reduced expression of this enzyme in cultured neurons results in re-
sensitization to Aβ (Newington et al. 2011; Newington et al. 2012).  These findings 
suggest that the conversion of pyruvate to lactate may play a role in conferring Aβ-
resistance. Although LDHB activity catalyzes the reverse reaction, which produces 
pyruvate and NADH from lactate and NAD+, its role has not been well characterized in 
AD models. A recent investigation by Ciavardelli et al. (2010), examining differential 
expression of LDHB in whole brain extracts of control and transgenic AD mice, reveals 
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significantly diminished expression of LDHB in the latter.  Interestingly, LDHB 
expression was significantly upregulated in the cerebellum, a brain region unaffected by  
Aβ accumulation (Ciavardelli et al. 2010).  Based on these results, the authors speculate 
that LDHB may be protective against AD pathology in brain tissue.  However, the role of 
LDHB in attenuating Aβ toxicity in neurons has yet to be determined. 
 
Intriguingly, both pyruvate and NADH have been implicated in reducing oxidative stress.  
First, NADH may fulfill an important role in glutathione and thioredoxin antioxidant 
defense mechanisms in neuronal mitochondria by mediating the regeneration of NADPH 
(Alvarez et al. 2003; Miranda-Vizuete et al. 2000; Vogel et al. 1999).  In these pathways, 
NADPH is a key substrate that fuels a series of reduction-oxidation reactions that 
ultimately detoxify H2O2.  NADPH regeneration is accomplished by NADP+ 
transhydrogenase, an IMM-localized enzyme that utilizes the H+ gradient across the IMM 
to drive electron transfer from NADH to NADP+ (Rydström 2006; Vogel et al. 1999).  
Interestingly, NADP+ transhydrogenase-mediated NADPH regeneration and glutathione 
antioxidant accumulation have been observed in rat forebrain mitochondria (Vogel et al. 
1999).  Thioredoxin enzymes, which are dependent on NADPH for antioxidant activity, 
are also protective in mammalian neuronal cell lines (Miranda-Vizuete et al. 2000).  
Second, in addition to being a central metabolic substrate, pyruvate has been shown to 
function as a potent antioxidant and can directly neutralize H2O2 and other peroxides via 
a non-enzymatic decarboxylation reaction (Constantopoulos and Barranger 1984; Vlessis 
et al. 1990).  Studies by Desagher et al. (1997) demonstrated that pyruvate protects 
against H2O2-induced neurotoxicity in mouse primary cortical neurons by undergoing 
non-enzymatic decarboxylation in the presence of H2O2.  Interestingly, pyruvate was 
neuroprotective at relatively low concentrations, whereas high concentrations were 
ineffective (Desagher et al. 1997).  In addition, lactate was not neuroprotective against 
H2O2 (Desagher et al. 1997).  Futhermore, Alvarez et al. (2003) showed that pyruvate 
protects against Aβ toxicity and reduces caspase-3 activation by limiting mitochondrial 
ROS accumulation and oxidative damage in rat primary cortical neurons.  Importantly, 
this protection was dependent upon the import of pyruvate into the mitochondria (Alvarez 
et al. 2003). Therefore, LDHB may mediate resistance to Aβ toxicity in neurons by 
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supplying substrates with the capacity to directly or indirectly limit Aβ–induced increases 
in Δψm and mitochondrial ROS levels.  This in turn, may reduce overall oxidative 
damage and protect against neurotoxicity.   
 
Investigations by Soucek et al. (2003) demonstrated that Aβ-resistant PC12 cells may 
exhibit increased production of pyruvate, compared to Aβ-sensitive cells, due to 
upregulated glycolytic activity.  Although pyruvate functions as a potent antioxidant in 
neuronal mitochondria exposed to Aβ (Alvarez et al. 2003), the importance of MPC 
activity, which facilitates the transport of pyruvate into the mitochondrial matrix, on 
neuronal viability has not been previously investigated.  In addition, MCTs have an 
important role in the transport of pyruvate and lactate, preventing the cytotoxic 
accumulation in the latter.  Aβ-resistant PC12 cells may therefore be more dependent on 
MCT activity, due to increased production of lactate. However, the effect of MCT 
inhibition on Aβ-resistant neuronal cell viability remains undetermined.   
 
Therefore, the role of LDHB in aerobic glycolysis-mediated resistance to Aβ will be the 
primary focus of this investigation.  In addition, the importance of the MPC as well as 
MCT1, 2, and 4 on viability will be evaluated in Aβ-resistant neuronal cells.  This study 
will utilize an Aβ-sensitive PC12 cell line (PC12-P) and two Aβ-resistant cell lines 
(PC12-R1 & R7) as model systems. I hypothesize that LDHB expression and activity 
are upregulated in mitochondria of Aβ-resistant PC12 cells, compared to the Aβ-
sensitive parental cell line, resulting in decreased mitochondrial Δψm, ROS levels, 
and cell death.  Additionally, compared to the sensitive cell line, I predict that Aβ-
resistant PC12 cell lines will be more sensitive to the chemical inhibition of MCTs as 
well as the MPC.   LDHB’s role will be evaluated using plasmid shRNA knockdown 
technologies in PC12 cells.  Experiments will be performed to ascertain whether 
knockdown of LDHB in PC12 cells will (1) promote increased levels of mitochondrial 
ROS, (2) induce increased Δψm, and (3) result in decreased cell viability when exposed to 
toxic concentrations of Aβ.  In addition, I will seek to elucidate whether LDHA and/or 
LDHB are localized to the mitochondria of PC12 cells. 
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Chapter 2: Materials and Methods 
 
2.1 – Cell Culture 
This investigation uses the immortalized, Aβ-sensitive PC12 nerve cell line (PC12-P) and 
its two Aβ-resistant derivatives (PC12-R1 & PC12-R7), provided by Dr. David Schubert 
(The Salk Institute, La Jolla, CA).  These cell lines are subclones of the original PC12 
clonal cell line, which itself, is derived from a rat pheochromocytoma.  Studies by Greene 
and Tischler (1976) demonstrate that the PC12 cell line possesses inherent sympathetic 
neuronal properties including synthesis and secretion of catecholamine neurotransmitters, 
as well as becoming post-mitotic and forming neuronal-like processes following 
treatment with nerve growth factor, making it a useful model system for the study of 
neuropathologies.  All PC12 cell lines were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) (Biowhittaker, Walkersville, MD, USA), supplemented with 10% fetal 
bovine serum (FBS) (PAA Laboratories Inc., Etobicoke, ON, Canada), 5% horse serum 
(HS) (PAA Laboratories Inc., Etobicoke, ON, Canada), and 1% penicillin/streptomycin 
(Biowhittaker, Walkersville, MD, USA).  PC12 cells were incubated at 37°C with 5% 
CO2.  For Aβ toxicity studies, PC12 cells were cultured in DMEM containing half the 
level of serum, to ensure optimal sensitivity to Aβ peptide, as serum metabolites may be 
protective against the neurotoxic effect of Aβ. 
 
2.2 – Construction of HuSH pRS shLDHB Vector & Derivation of LDHB-
knockdown PC12 Cell Lines 
To generate a rat LDHB knockdown vector derived from the HuSH pRS plasmid 
(OriGene, Rockville, MD), the coding sequence of rat LDHB was obtained from the 
National Center for Biotechnology Information database.  Using this information, a 
forward primer (Invitrogen, Carlsbad, CA, USA) corresponding to the U6 promoter of 
the pRS vector and a reverse primer encoding LDHB shRNA were generated by Eurofins 
MWG Operon.  The forward primer was 5’ - GGCGAATTCCCCAGTGGAAAGACG - 
3’.  The reverse primer was 5’ – 
AGAGGATCCAAAAAAGCCACTGGGTTGGAAACCACGATGATGGTGACC 
TCGAGCACACCATCATCGTGGTTTCCAACCCAGTGGCGCGTCCTTTCCACAAG
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ATATATAAAC – 3’.  Using the forward and reverse primers, as well as the U6 
promoter within the HuSH pRS plasmid vector (OriGene, Rockville, MD) as a template, 
an amplicon encoding the U6 promoter followed by LDHB shRNA was generated 
through a polymerase chain reaction (PCR) – based strategy.  The amplified sequence 
was digested with EcoRI and BamHI restriction enzymes (New England BioLabs, 
Ipswich, MA, USA), as the EcoRI and BamHI restriction sites were incorporated into the 
forward and reverse primers respectively.  The digested PCR product was then ligated 
into a pRS vector, previously digested with EcoRI and BamHI, yielding the HuSH pRS 
shLDHB vector.  
 
For the purposes of my investigation, PC12-R1 and R7 cells were seeded in 60 mm cell 
culture dishes (BD BioSciences) and allowed to achieve approximately 70-80% confluency.  
Cells were transfected with either a pRS scrambled shRNA vector (control) or the pRS 
shLDHB plasmid.  In accordance with standard transfection protocol, exactly 5µg of plasmid 
was added to 8µL of Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in 1mL of Opti-
MEM I transfection medium (Invitrogen, Carlsbad, CA, USA), and added to PC12 cells 
which were then incubated at 37°C (5% CO2, 95% O2) for 6 hours.  Transfection medium 
was replaced with normal DMEM and serum and allowed to recover at 37°C overnight.  To 
ensure stable expression of either the pRS scrambled or pRS shLDHB vector, transfected 
cells were placed in DMEM containing 2µg/mL puromycin, as both vectors encode a 
puromycin resistance gene.  Surviving clonal populations of PC12 cells transfected with the 
pRS shLDHB vector were screened for reduced LDHB protein expression, and compared 
against PC12 cells transfected with pRS scrambled vector, by immunoblot analysis. 
 
2.3 – Immunoblot Analysis 
To assess the expression levels of proteins of interest in the PC12 cell lines, cells were 
washed twice with 1x Dulbecco’s Phosphate Buffered Saline (DPBS) (Biowhittaker, 
Walkersville, MD, USA), and harvested with lysis buffer (2% SDS, 50 mM Tris pH=7.5, 
1 mM PMSF).  Whole cell lysates were then sonicated and centrifuged at 4°C for 10 
minutes at 13200 rpm.  Protein levels were quantified by Lowry assay using a colourimetric 
DC™ Protein Assay Kit (BioRad, Hercules, CA, USA).  Protein extracts were then 
reduced in 5X loading buffer containing 100 mM dithiothreitol (DTT) and 2% beta-
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mercaptoethanol (BME) and boiled for 5 minutes.  Protein samples were resolved on a 
12% polyacrylamide gel by SDS-PAGE using a Mini-PROTEAN® gel electrophoresis 
apparatus (BioRad, Hercules, CA, USA), and then transferred onto polyvinylidene 
fluoride (PVDF) membrane (BioRad, Hercules, CA, USA) by overnight electroblotting at 
4°C.  PVDF membrane was washed 3x for 5 minutes in Tris-buffered saline with 1% Tween-
20 (TBST), incubated in blocking solution (3% bovine serum albumin, 1% blotting milk) for 
at least 1 hour at room temperature, then washed with TBST another 3x for 5 minutes.  Each 
membrane was then probed with a single primary antibody overnight at 4°C.  The following 
antibodies were used in this investigation: polyclonal rabbit anti-LDHA 2012S (Cell 
Signaling, Danvers, MA, USA), monoclonal mouse anti-LDHB AF60H11 (AbFrontier, 
Seoul, South Korea), monoclonal mouse anti-Pyruvate Dehydrogenase E1-alpha subunit 
[8D10E6] ab110334 (Abcam, Cambridge, England, UK), monoclonal mouse anti-β-Actin 
A5441 (Sigma-Aldrich, St. Louis, MO, USA), polyclonal rabbit anti-Voltage Dependent 
Anion Channel (VDAC) (Cell Signaling, Danvers, MA, USA), monoclonal mouse anti-
HA.11 16B12 (Covance), polyclonal rabbit anti-Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (Imgenex), polyclonal rabbit anti-monocarboxylate transporter 1 (MCT1) 
(Millipore, Etobicoke, ON, Canada), polyclonal rabbit anti-monocarboxylate transporter 2 
(MCT2) (Millipore, Etobicoke, ON, Canada), polyclonal rabbit anti-monocarboxylate 
transporter 4 (MCT4) (Millipore, Etobicoke, ON, Canada).  After overnight incubation with 
the primary antibody, the PVDF membrane was washed 3x for 10 minutes in TBST and 
incubated in blocking solution (3% BSA, 1% blotting milk, 1:10000 secondary antibody) 
containing an appropriate secondary antibody at room temperature for at least 1 hour.  The 
following secondary antibodies were used in this investigation: blotting grade goat anti-rabbit 
IgG (H+L) Horseradish Peroxidase Conjugate 170-6515 (BioRad, Hercules, CA, USA) and 
blotting grade goat anti-mouse IgG (H+L) Horseradish Peroxidase Conjugate 170-6516 
(BioRad, Hercules, CA, USA).  Membranes were washed with TBST 3x for 5 minutes and 
developed using SuperSignal® West Pico Chemiluminescent Substrate (Thermo Scientific, 
Rockford, IL, USA).  Protein signal was detected by Molecular Imager® ChemiDoc™ XRS 
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2.4 – Trypan Blue Exclusion Test 
The effects of Aβ on viability of PC12-P, R1-Scram, R7-Scram, R1-shLDHB7, and R7-
shLDHB6 cells were assessed by trypan blue (VWR) dye exclusion test.  PC12 cells were 
seeded at 1x105 cells/well (PC12-P) or 2.5x104 cells/well (PC12-R1-Scram/R7-
Scram/R1-shLDHB7/R7-shLDHB6) in triplicate in 12-well dishes.  Cells were allowed 
to adhere overnight at 37°C.  The following day, cells were treated with 20µM Aβ(25 – 35) 
and incubated for 48 hours.  Following this treatment, cell media (containing non-
adherent, dead cells) from each well (1mL) was collected and placed in separate 15mL 
conical tubes (BD Biosciences).  Exactly 100µL of pre-warmed TrypLE Express 
(Invitrogen, Carlsbad, CA, USA) was added to live, adherent cells in each well, then 
incubated for 5 minutes at 37°C to allow cells to detach from the plates.  The collected cell 
media was added back to each respective well and placed back in separate 15mL conical 
tubes, yielding a suspension containing both live and dead cells.  Conical tubes were 
centrifuged at 500x g for 5 minutes, followed by the removal of the supernatant, yielding a 
pellet of live and dead cells that were then suspended in 100µL of media.  Exactly 100µL 
of trypan blue was added to each 100µL of cell suspension, mixed, and then loaded into a 
haemocytometer for counting.  Cells that excluded trypan blue (white) are viable, 
whereas those that are unable to exclude the dye (blue) are dead.  Cell viability was 
determined as a percentage based on the number of viable cells divided by the total 
number of cells per treatment. 
 
2.5 – Mitochondrial Isolation and Proteinase K Protection Assay 
The subcellular localization of LDHA and LDHB isoforms within neurons is highly 
debated among the scientific community, however, recent studies suggest both isoforms 
may localize within the mitochondria of rat neuronal cells (Hashimoto et al. 2008). The 
localization of LDHA and LDHB in the context of neuronal Aβ-resistance has not been 
previously investigated.  Therefore, this study sought to determine if LDHA or LDHB 
isoforms are localized within the mitochondria of Aβ-resistant PC12 cells, via a 
proteinase K protection assay, which has been used in past investigations to remove 
potential cytosolic contaminants from crude mitochondrial isolates (Hitosugi et al. 2011).  
Proteinase K is a highly reactive, yet stable proteolytic enzyme with broad substrate 
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specificity, while Triton X-100 is a non-ionic detergent that permeabilizes biological 
membranes.  Therefore, treatment of mitochondria with proteinase K alone results in the 
digestion of extramitochondrial proteins, while any intramitochondrial proteins are 
protected from digestion due to the mitochondrial double membrane.  However, 
treatment of mitochondria with Triton X-100 compromises mitochondrial membrane 
integrity, allowing proteinase K to digest both extra- and intramitochondrial proteins. 
 
To determine whether LDHA and/or LDHB proteins are predominantly localized in the 
mitochondria, subcellular fractionation of Aβ-resistant PC12 cells was performed.  
Mitochondria and cytosolic fractions were first isolated from PC12-R1 and R7 cells using 
a Mitochondria Isolation Kit for Mammalian Cells (Thermo Scientific, Rockford, IL, 
USA).  Isolated mitochondrial pellets were then resuspended in Hepes Buffer (20 mM 
Hepes, 0.28M Sucrose, 1 mM EDTA, 5 mM CaCl2) and subjected to the following 
treatments: 1) Untreated (Control), 2) 10µg/mL proteinase K incubated at 37°C for 3 
hours, and 3) 10µg/mL proteinase K + 1% Triton X-100 incubated at 37°C for 3 hours.  
Following incubation, proteinase K activity was inhibited with the protease inhibitor 
PMSF (5 mM final concentration), and mitochondria were lysed with 2% SDS.  
Mitochondrial lysates were then resolved by SDS-PAGE followed by immunoblot analysis. 
 
2.6 – Mitochondrial ROS Quantification in PC12 cells following Aβ exposure 
Visualization of mitochondrial ROS levels in PC12 cells was accomplished using the 
fluorescent dye MitoTracker Red CM-H2XRos (MTR) (Invitrogen, Carlsbad, CA, USA).  
MTR is a reduced dye that fluoresces upon its oxidation within mitochondria.  Therefore, 
increased fluorescence intensity may be indicative of elevated ROS levels.  Cells were 
seeded in 35 mm plastic cell culture dishes (pre-treated with 50µg/mL poly-D-lysine) at 
1x106 cells/dish (PC12-P) or 1x105 cells/dish (PC12-R1/R7) and incubated at 37°C 
overnight.  PC12 cells were then treated with 20µM Aβ(25 – 35) peptide for 48 hours.  
Following treatment, media was aspirated, replaced with media containing 100nM MTR, 
and incubated at 37°C for 20 minutes.  Cells were then washed in pre-warmed DPBS 
containing 10µg/mL Hoescht stain for an additional 20 minutes, washed with DPBS, and 
placed in phenol red-free DMEM for visualization by fluorescence microscopy (Zeiss-
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AxioObserver, 40x objective).  Images were taken from four random fields of view for 
each dish using a Q Imaging (Retiga 1300 monochrome 10-bit) camera with Q Capture 
software.  Fluorescent intensity of each image was quantified with ImageJ software. 
 
2.7 – Analysis of mitochondrial membrane potential in PC12 cells following Aβ 
exposure 
Mitochondrial membrane potential is generated by mitochondrial electron transport 
activity, which facilitates increased H+ transport from the mitochondrial matrix to the 
IMS.  In PC12 cells, Δψm was evaluated using the fluorescent dye tetramethylrhodamine 
methyl ester (TMRM) (Invitrogen, Carlsbad, CA, USA).  TMRM is a lipophilic, red 
fluorescent dye that is readily sequestered within the negatively charged matrix of active 
mitochondria.  Dissipation of Δψm induces leakage of TMRM from the matrix, and 
therefore, decreased fluorescent intensity.   Cells were seeded in 35 mm plastic cell 
culture dishes (pre-treated with 50µg/mL poly-D-lysine) at 1x106 cells/dish (PC12-P) or 
1x105 cells/dish (PC12-R1/R7) and incubated at 37°C overnight.  PC12 cells were then 
treated with 20µM Aβ(25 – 35) peptide for 48 hours.  Following treatment, media was 
aspirated, replaced with media containing 200nM TMRM, and incubated at 37°C for 20 
minutes.  Cells were then washed in pre-warmed DPBS containing 10µg/mL Hoescht stain 
for an additional 20 minutes, washed with DPBS, and placed in phenol red-free DMEM 
for visualization by fluorescence microscopy as previously described.  Fluorescent 
intensity of each image was quantified with ImageJ software. 
 
2.8 – MTT Assay 
Inhibition of MCTs and the MPC were accomplished chemically using the general MCT 
inhibitor, α-cyano-4-hydroxycinnamic acid (CHC), and the specific MPC inhibitor, UK-
5099.  The effect of UK-5099 and CHC on the viability of PC12-P, R1, and R7 cells was 
assessed using an MTT colourimetric assay, in which only viable cells are able reduce the 
tetrazolium dye MTT, forming purple formazan crystals that can be subsequently 
solubilized.  Non-viable cells are unable to produce these crystals. Therefore, the extent 
of purple colouring is indicative of the degree of viable cells.  UK-5099 and CHC are 
soluble in dimethyl sulfoxide (DMSO).  Each cell line was seeded in quadruplicate in a 
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96-well cell culture plate at 10,000 cells/well (PC12-P) or 4000 cells/well (PC12-R1/R7) 
in 100µL of phenol red-free DMEM and incubated overnight at 37°C.  For assessing the 
effect of UK-5099, media was removed and replaced with phenol red-free DMEM treated 
with 500µM or 1000µM UK-5099 dissolved in DMSO (1% final concentration).  For 
assessing the effect of CHC, media was removed and replaced with phenol red-free DMEM 
treated with 10 mM or 20 mM UK-5099 dissolved in DMSO (0.5% final concentration).  
PC12 cells were then incubated at 37°C for 24 and 48 hours.  Following treatment, 10µL of 
2.5 mg/mL MTT solution was added to each well and cells were incubated at 37 °C for 6 
hours.  After incubation, 100µL of MTT stop mix solution was added to each well, the 96-
well plate was rocked overnight at room temperature, and absorbance at 570 nm was 
measured, following subtraction of background absorbance at 690 nm, using a Tecan 
M1000 plate reader. 
 
2.9 – Statistical Analyses 
Cell viability data, MitoTracker® Red CM-H2XRos data measuring mitochondrial ROS, 
and TMRM data measuring mitochondrial membrane potential were evaluated by One-
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Chapter 3: Results 
 
3.1 – Basal levels of LDHB are elevated in Aβ-resistant PC12 cells 
Previous research has revealed that increased LDHA activity in PC12 cells promotes 
resistance to Aβ toxicity (Newington et al. 2011).  However, the potential role of LDHB 
in mediating Aβ resistance in PC12 cells has not been previously explored.  Therefore, a 
logical first step was to examine basal LDHB levels in PC12 cell lines.  Whole cell 
lysates from PC12-P, R1, and R7 cells treated with or without 20 µM Aβ(25 – 35) for 48 
hours were analyzed by immunoblot analysis using a primary antibody specific for 
LDHB (Figure 3).  LDHB levels exhibited an approximate 8-fold elevation in both Aβ-
resistant PC12 cell lines, compared to the sensitive parental cell line, and levels were 
unaffected by treatment with Aβ.  
 
3.2 – LDHA and LDHB are localized within the mitochondria of Aβ-resistant PC12 
cells 
Mitochondria of PC12-R1 and R7 cells were isolated and incubated with proteinase K 
(10 µg/mL) in the absence or presence of Triton X-100 (1%) for 3 hours at 37 °C (Figure 
4).  This assay has been used previously in past studies to rule out the possibility of 
cytosolic protein contaminants in crude mitochondrial isolates (Hitosugi et al. 2011).  
Mitochondrial lysates were analyzed by immunoblot analysis, using primary antibodies 
specific for either LDHA or LDHB isoforms.  Under control conditions, LDHA and 
LDHB were localized within the mitochondria of both resistant PC12 cell lines.  LDHA 
and LDHB isoforms were partially protected from digestion when mitochondria are 
treated with proteinase K alone, but were digested when treated with proteinase K in the 
presence of Triton X-100.  Additionally, mitochondrial lysates under each treatment were 
probed with antibodies specific for GAPDH, VDAC, and PDH-E1α to assess the purity 
of mitochondrial fractions and to ensure proper activity of proteinase K and Triton X-
100.  These data suggest that both the LDHA and LDHB isoforms were localized within 
the mitochondria of Aβ-resistant PC12 cells. 
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Figure 3. LDHB expression is increased in Aβ-resistant PC12 clonal cell lines.  A) 
Immunoblot analysis of PC12-P, R1, and R7 whole cell lysates reveals elevated LDHB 
protein levels in both Aβ-resistant PC12 clonal cell lines, compared to the parental cell 
line.  Treatment with 20 µM Aβ for 48 hours did not appear to affect LDHB levels.  B) 
Densitometric analysis reveals an approximate 8-fold elevation of LDHB levels in 
resistant PC12 cell lines treated with or without Aβ, compared to the parental cell line, in 
which LDHB levels were barely detectable.  An anti- β-actin antibody was used as a 
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Figure 4. LDHA and LDHB isoforms are localized within the mitochondria of Aβ-
resistant PC12 clonal cell lines. Immunoblot analysis of PC12-R1 and R7 mitochondrial 
pellets treated with or without proteinase K (10 µg/mL) in the presence or absence of 
Triton X-100 (1%) for 3 hours.  LDHA and LDHB levels were partially protected in R1 
and R7 mitochondrial pellets treated with proteinase K alone, but were almost completely 
absent when treated with proteinase K + Triton X-100, compared to control conditions.  
In addition, the blot was reprobed with an anti-GAPDH antibody to assess any potential 
cytosolic contamination of the mitochondrial fraction.  Furthermore, the blot was also 
probed with anti-VDAC and anti-PDHE1α antibodies to assess the purity of 
mitochondrial isolates and proper functionality of proteinase K and Triton X-100.  These 
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3.3 – Derivation of LDHB knockdown in PC12 clonal cell lines 
To determine if LDHB is important in mediating resistance to Aβ toxicity, LDHB levels 
were knocked down in Aβ-resistant PC12 cells using shRNA that specifically targeted 
the LDHB transcript. PC12-R1 and R7 cells were transfected with the HuSH 
pRS(shLDHB) vector and selected with puromycin (2 µg/mL).  Whole cell lysates from 
surviving clones were subsequently screened by immunoblotting, using primary 
antibodies specific to either the LDHB or LDHA isoforms.  R1 and R7 clonal cells stably 
expressing the pRS(shLDHB) vector (clones 7 and 6, respectively) exhibited reduced 
LDHB levels compared to untransfected (UT) or pRS(Scram)-transfected R1 and R7 
cells (Figure 5A and 5B).  LDHA levels remained constant across UT, pRS(Scram)-, and 
pRS(shLDHB)-transfected R1 and R7 clonal cell lines demonstrating the specificity of 
the shRNA to target only the LDHB isoform.  Densitometric analyses revealed LDHB 
levels were significantly reduced (p < 0.001) by nearly 60% in R1-shLDHB7 and R7-
shLDHB6 cells compared to R1-Scram and R7-Scram cells, respectively, while LDHA 
levels were not significantly altered (Figure 5C and 5D).  Together, these data indicated 
that the HuSH pRS(shLDHB) vector construct was stably expressed in Aβ-resistant PC12 
cells and specifically reduced LDHB levels without affecting levels of LDHA. 
 
3.4 – LDHB knockdown re-sensitizes resistant PC12 cells to Aβ toxicity 
The effect of LDHB knockdown on PC12 cell viability, following treatment with 20 µM 
Aβ for 48 hours, was evaluated by trypan blue exclusion assay (Figure 6).  Cell viability 
was significantly reduced (p < 0.001) to approximately 60% in PC12-P, R1-shLDHB7, 
and R7-shLDHB6 cells treated with Aβ, compared to parental cells treated without Aβ.  
Conversely, R1-Scram or R7-Scram cells maintained high cell viability under both 
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Figure 5. Derivation of LDHB knockdown PC12 clonal cell lines. Immunoblot 
analysis of A) PC12-R1 and B) R7 cells untransfected (UT) or stably transfected with 
either pRS (Scrambled) vector or a pRS vector containing rat LDHB shRNA revealed a 
clonal cell line (clone 7 and 6, respectively) with significantly reduced LDHB protein 
expression levels (*, p < 0.001).  LDHA protein levels remained constant across 
treatment groups.  C) Densitometric analyses of LDHB and D) LDHA protein levels 
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Figure 6. Knockdown of LDHB expression results in re-sensitization to Aβ toxicity 
in resistant PC12 cells.  Cell viability of PC12 parental and resistant LDHB knockdown 
clonal cell lines treated with Aβ (20 µM) for 48 hours was significantly decreased 
compared to parental cells treated without Aβ (*, p < 0.001).  Data presented are the 
mean of three independent experiments.  Viability of all treatment groups were compared 
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3.5 – LDHB knockdown increases mitochondrial ROS levels in the presence of Aβ 
To measure the impact of LDHB knockdown on mitochondrial ROS levels, live PC12 
cells were stained with MitoTracker Red CM-H2XRos (MTR) following treatment with 
20 µM Aβ for 48 hours.  PC12 cells were then visualized by fluorescence microscopy and 
images were taken at 400x magnification (Figure 7A).  Quantification of fluorescence 
intensity revealed a significant increase of approximately 50% (p < 0.05) in PC12-P and 
R1-shLDHB7 cells treated with Aβ, compared to parental cells not treated with Aβ 
(Figure 7B).  Fluorescence intensity appeared elevated, but not significantly, in R7-
shLDHB6 cells treated with Aβ compared to parental cells not treated with Aβ.   In 
addition, no significant difference in fluorescence intensity was observed in R1-Scram 
and R7-Scram cells under control and Aβ treatments, compared to parental cells treated 
without Aβ.   
 
3.6 – LDHB knockdown increases mitochondrial membrane potential in the 
presence of Aβ 
To evaluate the effect of LDHB knockdown on Δψm, live PC12 cells were stained with 
TMRM following exposure to 20 µM Aβ for 48 hours. PC12 cells were visualized by 
fluorescence microscopy and images were taken at 400x magnification (Figure 8A).  
Quantification analysis revealed fluorescence intensity was significantly elevated (p < 
0.05) in parental (~60%), R1-shLDHB7 (~30%) and R7-shLDHB6 (~60%) cells treated 
with Aβ, compared to parental cells treated without Aβ (Figure 8B).  Fluorescence 
intensity was not significantly different in Aβ- and control-treated R1-Scram or R7-
Scram cells, compared to parental cells treated without Aβ.   
 
3.7 – Basal levels of MCT1, 2, and 4 are elevated in Aβ-sensitive PC12 cells 
Lactate is transported across the plasma membrane and other intracellular membranes via 
a family of monocarboxylate (MCT) transporters.  To determine if MCT levels were 
altered in resistant versus sensitive cells, MCT1, 2, and 4 protein expression was assessed 
in PC12-P, R1, and R7 cells, treated with or without 20 µM Aβ for 48 hours by 
immunoblotting using primary antibodies specific for either MCT1, 2, or 4 (Figure 9).   
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Figure 7. LDHB knockdown in Aβ-resistant PC12 cells results in increased 
mitochondrial reactive oxygen species levels.  A) Mitochondrial reactive oxygen 
species (ROS) levels were measured in PC12 cells following staining with the red 
fluorescent dye MitoTracker Red CM-H2XRos (MTR).  Parental and Aβ-resistant PC12 
clonal cell lines with knocked down LDHB levels exhibited elevated fluorescence 
intensity following exposure to Aβ (20 µM) for 48 hours compared to parental cells 
treated without Aβ.  Nuclei were stained with Hoescht stain (blue) and images were 
visualized by fluorescence microscopy at 400x magnification.  B) Quantification of MTR 
fluorescent images revealed that fluorescence intensity was significantly increased in Aβ-
treated parental and R1-shLDHB7 cells compared to parental cells treated without Aβ (*, 
p < 0.05).  MTR fluorescence intensity appeared elevated in Aβ-treated R7-shLDHB6 
cells, but not significantly different compared to parental cells treated without Aβ.    Data 
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Figure 8. Knockdown of LDHB protein expression results in increased 
mitochondrial membrane potential in resistant PC12 cells treated with Aβ.  A) 
Mitochondrial membrane potential (Δψm) was measured in PC12 cells following staining 
with the red fluorescent dye TMRM.  Parental and Aβ-resistant PC12 clonal cell lines 
with knocked down LDHB levels exhibited elevated fluorescence intensity following 
exposure to Aβ (20 µM) for 48 hours compared to parental cells treated without Aβ.  
Nuclei were stained with Hoescht stain (blue) and visualized by fluorescence microscopy 
at 400x magnification.  B) Quantification of TMRM fluorescent images revealed that 
fluorescence intensity was significantly increased in Aβ-treated PC12-P and LDHB 
knockdown PC12-R1 and R7 cell lines compared with parental cells in the absence of Aβ 
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Figure 9.  MCT1, 2, and 4 levels are decreased in Aβ-resistant PC12 clonal cell lines.  
Immunoblot analysis of PC12-P, R1, and R7 whole cell lysates revealed decreased MCT 
1, 2, and 4 protein levels in both Aβ-resistant PC12 clonal cell lines, compared to the 
parental cell line.  Treatment with 20 µM Aβ for 48 hours did not appear to affect LDHB 
levels.  An anti- β-actin antibody was used as a loading control.  These results were 
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MCT1, 2, and 4 protein levels were elevated in PC12-P cells, compared to both Aβ-
resistant PC12 cell lines, and were unaffected by Aβ treatment. 
 
3.8 – CHC-induced MCT inhibition results in decreased viability in Aβ-resistant 
PC12 cells 
As previously discussed, accumulation of toxic levels of lactate is prevented by transport 
of this metabolite across biological membranes via MCTs.  Thus, the effect of chemical 
inhibition of MCTs was examined in Aβ-sensitive and resistant PC12 cell lines.  PC12-P, 
R1, and R7 cells were treated with CHC (10 mM and 20 mM) for 24 or 48 hours (Figure 
10).  Cell viability was measured by a MTT colourimetric assay.  Treatment of PC12-P 
cells with CHC (10 mM and 20 mM) resulted in a significant reduction in cell viability 
(*, p < 0.05), compared to parental cells treated without CHC, for both time-points.  In 
contrast, cell viability was not significantly reduced in R1 or R7 cells, when treated for 
either 24 or 48 hours with 10 mM CHC, compared to untreated parental cells.   Although 
R1 or R7 cells exhibited increased cytotoxicity following 20 mM CHC exposure, both 
resistant cell lines displayed higher viability compared to the parental cell line treated 
under the same conditions and same time.   
 
3.9 – UK-5099-mediated inhibition of the mitochondrial pyruvate carrier results in 
decreased viability in PC12 cells 
As previously mentioned, pyruvate levels in Aβ-resistant PC12 cells may be elevated due 
to increased glycolytic activity (Soucek et al. 2003).  Since pyruvate acts as an important 
antioxidant and energy substrate in neuronal mitochondria, the importance of the MPC, 
which imports cytosolic pyruvate into the mitochondria, on PC12 cell viability was 
investigated. The effect of MPC inhibition on PC12-P, R1, and R7 cell viability was 
evaluated following treatment with 500 or 1000 µM UK-5099 for 48 hours (Figure 11).  
Cell viability was measured by a MTT colourimetric assay.  A 48-hour treatment of 
PC12-P, R1, and R7 cells with either concentration of UK-5099 resulted in a significant 
reduction (approximately 60 – 80%) in cell viability (*, p < 0.05), compared to parental 
cells not treated with UK-5099.   These findings indicate that both Aβ-sensitive and 
resistant cells are dependent on pyruvate transport into the mitochondria for survival. 
T.	  Tam	  Thesis	   	   	   	  
	  
47	  
Figure 10. Chemical inhibition of MCT1, 2, and 4 results in decreased viability in 
Aβ-resistant PC12 cells.  Viability of PC12-P cells was significantly reduced (*, p < 
0.05) when treated with 10 mM or 20 mM CHC, compared to untreated parental cells, 
following a 24 or 48-hour incubation period. PC12-R1 and R7 cell viability was not 
significantly altered following treatment with 10 mM CHC, compared to parental cells 
treated without CHC, for both 24 and 48-hour time-points.  For both time-points, viability 
of resistant cell lines was significantly decreased (#, p < 0.05) following 20 mM CHC 
exposure, compared to untreated parental cells, but higher than parental cells treated 
under the same conditions and same time-points.  Data presented are the mean ± SEM of 
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Figure 11.  UK-5099–mediated mitochondrial pyruvate carrier inhibition results in 
decreased viability in PC12 cells.  Viability of PC12-P, R1, and R7 cells was 
significantly reduced (*, p < 0.05) when treated with 500 µM or 1000 µM UK-5099 for 
48 hours, compared to parental cells treated without UK-5099.  Data presented are the 
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Chapter 4: Discussion & Future Research 
 
4.1 – Overview 
Although past studies have established LDHA activity as an important factor in neuronal 
protection against Aβ toxicity, this investigation sought to characterize LDHB’s potential 
role in mediating resistance to Aβ.  In addition, the subcellular compartmentalization of 
LDHA and LDHB remains highly disputed by the scientific community, although a 
recent study indicated that both LDH isoforms are localized to the mitochondria of rat 
hippocampal and cortical neurons (Hashimoto et al. 2008).  Therefore, mitochondrial 
localization of the specific LDH isoforms in PC12 cells was also examined in this 
investigation.  The findings of this study suggest that LDHB may be important in 
reducing oxidative stress and mediating resistance to Aβ neurotoxicity.  Furthermore, 
both LDHB and LDHA localize within the mitochondria of Aβ-resistant neuronal cells.  
Finally, general monocarboxylate transporter inhibition is tolerated in Aβ-resistant cells, 
but inhibition of the mitochondrial pyruvate carrier causes a decline in viability in both 
Aβ-sensitive and resistant PC12 cell lines. 
 
4.2 – LDHB and LDHA are localized in the mitochondria of Aβ-resistant PC12 cells 
Preliminary results of this investigation revealed that LDHB levels are elevated in Aβ-
resistant versus sensitive PC12 cells (Figure 3).  Interestingly, past studies by Newington 
et al. (2011) revealed that LDHA activity is also increased in Aβ-resistant versus 
sensitive PC12 cells.  Although LDHB and LDHA have antagonistic functions, these 
observations may be partially addressed by the aforementioned ILS hypothesis (Figure 
2).  Differential compartmentalization of LDHB and LDHA in the cytosol or 
mitochondria, as proposed by this hypothesis, may allow each isoform to fulfill their 
respective functions, without interfering with one another’s activities.  The mitochondrial 
Proteinase K Protection Assay confirmed that both LDHB and LDHA are localized 
within the mitochondria of resistant PC12 cells.  These results support the proposed 
hypothesis of this study, as well as previous work, in which LDHB and LDHA were 
suggested to localize within rat neuronal mitochondria, both in vitro and in vivo (Alante 
et al. 2007, Hashimoto et al. 2008).  Despite being localized within mitochondria, the 
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relative levels and activities of LDHB and LDHA associated with the OMM, IMS, IMM, 
and mitochondrial matrix, have not been well determined.  Therefore, mitochondrial 
subfractionation studies should be performed to investigate any differential 
compartmentalization of LDHB and LDHA in neuronal mitochondria.  In addition, 
examining LDHB and LDHA localization in PC12 cells by immunofluorescence 
microscopy using isoform-specific antibodies would provide strong evidence to support 
the results of this study, and thus merits further research.  Furthermore, additional studies 
should be conducted to ascertain the mitochondrial sublocalization of the LDH 
isoenzymes (LDH1-5).  Identification of the LDH isoenzymes may be accomplished by 
gel electrophoretic zymography. 
 
4.3 – LDHB mediates Aβ-resistance by reducing ROS levels and oxidative damage-
induced neurotoxicity 
Aβ may promote its neurotoxic effect by increasing mitochondrial ROS levels and Δψm, 
leading to widespread oxidative damage in sensitive cells.  Comparative analysis of 
PC12-P, R1, and R7 whole cell lysates revealed that LDHB levels are elevated in Aβ-
resistant versus sensitive cell lines (Figure 3), providing preliminary evidence that LDHB 
may play an important role in mediating resistance to Aβ in PC12 cells.   In addition, an 
increase in MTR and TMRM fluorescent intensity, as well as a decrease in cell viability, 
was observed in PC12-P and pRS(shLDHB)-expressing R1 and R7 cells when treated 
with Aβ (20µM) for 48 hours, compared to control-treated parental cells (Figures 6, 7, 8).  
In contrast, PC12-R1 and R7 control cells under the same treatment conditions did not 
exhibit increased MTR and TMRM fluorescent intensity, or decreased cell viability, 
compared to parental cells treated without Aβ.  Therefore, these findings indicate that 
LDHB may protect against Aβ-induced oxidative damage and neurotoxicity, as 
knockdown of LDHB in resistant PC12 cells promotes increased Δψm and mitochondrial 
ROS levels, as well as re-sensitization to Aβ toxicity.  As previously discussed, LDHB 
activity yields pyruvate and NADH, both of which limit increases in Δψm, neutralize 
mitochondrial ROS, and prevent oxidative stress-related neurotoxicity (Alvarez et al. 
2003; Miranda-Vizuete et al. 2000; Vogel et al. 1999; Constantopoulos and Barranger 
1984; Vlessis et al. 1990; Desagher et al. 1997).  Taken together with the present 
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findings, this suggests that LDHB knockdown in resistant PC12 cells may reduce 
available levels of pyruvate and NADH, compromising their ability to neutralize 
potentially harmful ROS and increasing the likelihood of oxidative damage-related 
neurotoxicity.  Collectively, these data support the proposed hypothesis and suggest 
LDHB is protective against Aβ-induced oxidative stress and neurotoxicity, however the 
exact mechanism by which this occurs is not fully elucidated.  
 
Further investigations are required to better characterize the role of LDHB in mediating 
resistance against Aβ-induced neurotoxicity.  For example, LDHB activity in the PC12-P, 
R1, and R7 cell lines should be assessed to complement the present findings, which 
primarily focused on overall LDHB levels.  Since LDHB catalyzes the conversion of 
lactate to pyruvate using NAD+ as a co-substrate, LDHB activity may be evaluated by 
measuring the reduction of NAD+ to NADH.  Additional studies should also examine the 
activity and levels of LDH1-5 in the PC12 clonal cell lines.  Additionally, the effect of 
LDHB overexpression on mitochondrial ROS levels, Δψm, and viability, in PC12 
sensitive cells treated with Aβ, should also be investigated.  Furthermore, it should be 
determined whether or not Aβ-resistant PC12 cells exhibit increased NADP+ 
transhydrogenase levels and activity, compared to parental cells, to determine if NADH-
mediated regeneration of NADPH may be an important factor in limiting mitochondrial 
ROS levels. 
 
4.4 – Impairment of monocarboxylate transport decreases PC12 cell viability 
Since the Aβ-resistant PC12 cell lines presumably need to export higher volumes of 
lactate, it was expected that they would be more sensitive to MCT inhibition than the 
parental cell line.  Contrary to these expectations, the findings of this study indicate that 
MCT1, 2, and 4 levels are lower in the PC12-R1 and R7 cell lines compared to the 
parental cell line.   CHC-mediated MCT inhibition is also tolerated in both Aβ-resistant 
PC12 cell lines, but not in the PC12-P cell line.  Taken together with studies by 
Newington et al. (2011), which demonstrate extracellular lactate accumulation in PC12 
cells, these results suggest the existence of a currently unknown alternate lactate 
transporter (ALT) that may facilitate lactate export in Aβ-resistant cell lines.  In addition, 
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to evaluate the importance of pyruvate import into the mitochondria, MPC activity was 
chemically inhibited by UK-5099 in PC12 cells.  Interestingly, PC12-P, R1, and R7 cells 
were intolerant of UK-5099–mediated inhibition of the MPC.  This suggests that Aβ-
sensitive and resistant cell lines are reliant on pyruvate import into the mitochondria.  To 
further complement these findings, MPC, as well as MCT1, 2, and 4 activities, should be 
examined in the PC12-P, R1, and R7 cell lines treated with and without Aβ.  
Additionally, the effect of monocarboxylate transport inhibition on PC12 cell viability 
should be examined using inducible knockdown vector constructs specific for MCT1, 2, 
4, as well as the MPC.  Furthermore, Aβ-resistant PC12 cells exhibit elevated 
extracellular levels of lactate (Newington et al. 2011). To confirm the possible existence 
of an ALT, extracellular lactate levels should be measured from Aβ-resistant PC12 cells 
in which MCT activity is chemically or genetically inhibited.  
 
4.5 – Conclusions 
This study provides novel insight into the role of lactate metabolism on neuronal Aβ 
resistance.  Past research indicates that increased LDHA activity, as observed in Aβ-
resistant neuronal cell lines, is protective against Aβ-induced oxidative stress and 
neurotoxicity.  However, LDHB’s role in protecting against Aβ toxicity has never been 
previously explored and was therefore the focus of this work.  Using Aβ-sensitive and 
resistant PC12 clonal cell lines as an experimental model, this investigation 
demonstrated, for the first time, that LDHB is important in mediating resistance to Aβ-
induced neurotoxicity in PC12 cells by potentially limiting Δψm and levels of 
mitochondrial ROS.  A proposed model outlining LDHB’s neuroprotective role against 
Aβ-induced oxidative damage is outlined below (Figure 12).  In addition, this study 
provides confirmation that both LDHA and LDHB are localized within the mitochondria 
of Aβ-resistant PC12 cells.  Interestingly, this work also indicates that although Aβ-
resistant cells are tolerant of general monocarboxylate transporter inhibition and sensitive 
cells are not, all PC12 clonal cell lines are reliant on MPC activity.  Although further 
study is warranted, this investigation lays the foundation for understanding how the 
transport and metabolism of lactate and its derivatives may be protective against the 
neurotoxic effect of Aβ. 
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Figure 12. Proposed mechanism by which LDHB protects against Aβ-induced 
oxidative damage in resistant PC12 cells.  Amyloid β (Aβ) promotes mitochondrial 
electron transport chain (ETC) dysfunction and H+ accumulation in the mitochondrial 
intermembrane space (IMS), resulting in increased production of reactive oxygen species 
(ROS).  Increasing ROS levels subsequently promote widespread oxidative damage and 
neurotoxicity.  Aβ-resistant PC12 cells exhibit increased activity of glycolytic enzymes as 
well as lactate dehydrogenase A (LDHA), lactate dehydrogenase B (LDHB), and 
pyruvate dehydrogenase kinase 1 (PDK1).  Elevated levels of glycolytic enzymes 
promote the conversion of glucose to pyruvate in the cytosol.  Increased LDHA activity 
then promotes the reduction of pyruvate to lactate, coupled with the oxidation of NADH 
to NAD+.  Co-transport of lactate with H+ into the mitochondrial matrix is facilitated by 
either a monocarboxylate transporter (MCT) or currently unknown, alternate lactate 
transporter (ALT) and may help dissipate the H+ gradient across the inner mitochondrial 
membrane (IMM).  Increased LDHB levels in the matrix facilitate oxidation of lactate to 
pyruvate, coupled with the reduction of NAD+ to NADH.  Alternatively, cytosol-
localized pyruvate may be co-transported with H+ into the mitochondrial matrix via the 
MPC.  Additionally, increased PDK1 activity promotes the phosphorylation and 
inhibition of pyruvate dehydrogenase (PDH), limiting the conversion of pyruvate to 
acetyl-CoA.  Therefore, mitochondrial matrix-localized pyruvate may directly neutralize 
potentially harmful ROS via a non-enzymatic decarboxylation reaction.  Furthermore, 
NADP+ transhydrogenase may utilize NADH and IMS-localized H+ to drive the 
regeneration of NADPH, a key substrate of the glutathione and thioredoxin antioxidant 
defense mechanisms.  Thus, LDHB promotes increased levels of pyruvate and NADH in 
the mitochondrial matrix, which may provide direct and indirect mechanisms to detoxify 
Aβ-derived ROS, resulting in reduced oxidative damage and neurotoxicity. 
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